Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matt Hewitt's Stock Ratings
Craig-Hallum Analyst
Matt Hewitt is an analyst at Craig-Hallum. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/21/2025
Overall Average Return
4.75%
Smart Score
Overall Average Return Percentile
48th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/13/2025 | SLP | Buy Now | Simulations Plus | $17.33 | 107.73% | Matt Hewitt56% | $45 → $36 | Maintains | Buy | Get Alert |
| 03/12/2025 | CSBR | Buy Now | Champions Oncology | $8.29 | 44.75% | Matt Hewitt56% | $8 → $12 | Maintains | Buy | Get Alert |
| 12/12/2024 | CSBR | Buy Now | Champions Oncology | $8.29 | -3.5% | Matt Hewitt56% | $6 → $8 | Maintains | Buy | Get Alert |
| 11/13/2024 | BLFS | Buy Now | BioLife Solns | $21.22 | 50.8% | Matt Hewitt56% | $30 → $32 | Maintains | Buy | Get Alert |
| 10/31/2024 | OMCL | Buy Now | Omnicell | $28.03 | 128.33% | Matt Hewitt56% | $45 → $64 | Maintains | Buy | Get Alert |
| 09/12/2024 | CSBR | Buy Now | Champions Oncology | $8.29 | -27.62% | Matt Hewitt56% | $6 → $6 | Upgrade | Hold → Buy | Get Alert |
| 08/12/2024 | BLFS | Buy Now | BioLife Solns | $21.22 | 41.38% | Matt Hewitt56% | $23 → $30 | Maintains | Buy | Get Alert |
| 07/09/2024 | LGND | Buy Now | Ligand Pharmaceuticals | $114.07 | 22.73% | Matt Hewitt56% | $135 → $140 | Maintains | Buy | Get Alert |
| 07/03/2024 | SLP | Buy Now | Simulations Plus | $17.33 | 223.14% | Matt Hewitt56% | $56 → $56 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2024 | SLP | Buy Now | Simulations Plus | $17.33 | 223.14% | Matt Hewitt56% | $51 → $56 | Maintains | Buy | Get Alert |
| 05/16/2024 | NOTV | Buy Now | Inotiv | $2.04 | 390.2% | Matt Hewitt56% | $25 → $10 | Maintains | Buy | Get Alert |
| 05/02/2024 | SDGR | Buy Now | Schrodinger | $20.71 | 44.86% | Matt Hewitt56% | $35 → $30 | Maintains | Buy | Get Alert |
| 03/13/2024 | CSBR | Buy Now | Champions Oncology | $8.29 | — | Matt Hewitt56% | — | Downgrade | Buy → Hold | Get Alert |
| 01/29/2024 | SNCE | Buy Now | Science 37 Hldgs | — | — | Matt Hewitt56% | — | Downgrade | Buy → Hold | Get Alert |
| 01/19/2024 | SDGR | Buy Now | Schrodinger | $20.71 | 69% | Matt Hewitt56% | $40 → $35 | Maintains | Buy | Get Alert |
| 01/04/2024 | SLP | Buy Now | Simulations Plus | $17.33 | 194.29% | Matt Hewitt56% | $50 → $51 | Maintains | Buy | Get Alert |
| 01/04/2024 | AGTI | Buy Now | Agiliti | — | — | Matt Hewitt56% | → $23 | Initiates | → Buy | Get Alert |
| 12/12/2023 | NOTV | Buy Now | Inotiv | $2.04 | 1125.49% | Matt Hewitt56% | $34 → $25 | Maintains | Buy | Get Alert |
| 12/08/2023 | CDMO | Buy Now | Avid Bioservices | — | — | Matt Hewitt56% | $22 → $16 | Maintains | Buy | Get Alert |
| 11/29/2023 | MXCT | Buy Now | MaxCyte | $2.04 | 243.14% | Matt Hewitt56% | → $7 | Initiates | → Buy | Get Alert |
| 08/10/2023 | BLFS | Buy Now | BioLife Solns | $21.22 | 8.39% | Matt Hewitt56% | $29 → $23 | Maintains | Buy | Get Alert |
| 08/03/2023 | RGEN | Buy Now | Repligen | $118.75 | 68.42% | Matt Hewitt56% | $207 → $200 | Maintains | Buy | Get Alert |
| 07/11/2023 | BLFS | Buy Now | BioLife Solns | $21.22 | 36.66% | Matt Hewitt56% | → $29 | Initiates | → Buy | Get Alert |
| 04/13/2023 | OABI | Buy Now | OmniAb | $1.52 | 557.89% | Matt Hewitt56% | → $10 | Initiates | → Buy | Get Alert |
| 03/31/2023 | SRGA | Buy Now | Surgalign Holdings | — | — | Matt Hewitt56% | $5 → $2 | Maintains | Hold | Get Alert |
| 07/07/2022 | SLP | Buy Now | Simulations Plus | $17.33 | 246.22% | Matt Hewitt56% | $55 → $60 | Maintains | Buy | Get Alert |
| 06/07/2022 | SNCE | Buy Now | Science 37 Hldgs | — | — | Matt Hewitt56% | → $10 | Initiates | → Buy | Get Alert |
| 05/24/2022 | CTEK | Buy Now | CynergisTek | — | — | Matt Hewitt56% | $3 → $1.25 | Downgrade | Buy → Hold | Get Alert |
| 04/28/2022 | TDOC | Buy Now | Teladoc Health | $6.91 | 334.15% | Matt Hewitt56% | $67 → $30 | Maintains | Hold | Get Alert |
| 02/23/2022 | TDOC | Buy Now | Teladoc Health | $6.91 | 869.6% | Matt Hewitt56% | $82 → $67 | Maintains | Hold | Get Alert |
| 01/04/2022 | ISPC | Buy Now | iSpecimen | $1.00 | 1900% | Matt Hewitt56% | → $20 | Initiates | → Buy | Get Alert |
| 12/08/2021 | CDMO | Buy Now | Avid Bioservices | — | — | Matt Hewitt56% | $29 → $35 | Maintains | Buy | Get Alert |
| 11/03/2021 | OMCL | Buy Now | Omnicell | $28.03 | 631.36% | Matt Hewitt56% | $170 → $205 | Maintains | Buy | Get Alert |
| 10/26/2021 | SLP | Buy Now | Simulations Plus | $17.33 | 205.83% | Matt Hewitt56% | $65 → $53 | Upgrade | Hold → Buy | Get Alert |
| 09/28/2021 | SRGA | Buy Now | Surgalign Holdings | — | — | Matt Hewitt56% | → $1.5 | Downgrade | Buy → Hold | Get Alert |
| 09/27/2021 | RGEN | Buy Now | Repligen | $118.75 | 209.89% | Matt Hewitt56% | $258 → $368 | Maintains | Buy | Get Alert |
| 09/20/2021 | NOTV | Buy Now | Inotiv | $2.04 | 2105.88% | Matt Hewitt56% | → $45 | Initiates | → Buy | Get Alert |
| 06/30/2021 | CDMO | Buy Now | Avid Bioservices | — | — | Matt Hewitt56% | $21 → $29 | Maintains | Buy | Get Alert |
| 05/25/2021 | SDGR | Buy Now | Schrodinger | $20.71 | 310.43% | Matt Hewitt56% | → $85 | Initiates | → Buy | Get Alert |
| 01/12/2021 | SLP | Buy Now | Simulations Plus | $17.33 | — | Matt Hewitt56% | — | Downgrade | Buy → Hold | Get Alert |
| 10/21/2020 | LGND | Buy Now | Ligand Pharmaceuticals | $114.07 | 70.95% | Matt Hewitt56% | $215 → $195 | Maintains | Buy | Get Alert |
| 07/28/2020 | VCRA | Buy Now | Vocera Communications | — | — | Matt Hewitt56% | $21 → $30 | Upgrade | Hold → Buy | Get Alert |
| 01/06/2020 | SLP | Buy Now | Simulations Plus | $17.33 | 130.81% | Matt Hewitt56% | → $40 | Initiates | → Buy | Get Alert |
| 10/25/2019 | VCRA | Buy Now | Vocera Communications | — | — | Matt Hewitt56% | → $21 | Downgrade | Buy → Hold | Get Alert |
| 10/16/2019 | CDMO | Buy Now | Avid Bioservices | — | — | Matt Hewitt56% | → $11 | Initiates | → Buy | Get Alert |
| 07/26/2019 | OMCL | Buy Now | Omnicell | $28.03 | 203.25% | Matt Hewitt56% | → $85 | Upgrade | Hold → Buy | Get Alert |
| 04/26/2019 | OMCL | Buy Now | Omnicell | $28.03 | — | Matt Hewitt56% | — | Downgrade | Buy → Hold | Get Alert |
| 07/27/2018 | OMCL | Buy Now | Omnicell | $28.03 | — | Matt Hewitt56% | — | Upgrade | Hold → Buy | Get Alert |
| 06/05/2018 | TDOC | Buy Now | Teladoc Health | $6.91 | — | Matt Hewitt56% | — | Upgrade | Hold → Buy | Get Alert |
| 07/24/2017 | APEN | Buy Now | Apollo Endosurgery | — | — | Matt Hewitt56% | → $11 | Initiates | → Buy | Get Alert |
| 05/12/2017 | TDOC | Buy Now | Teladoc Health | $6.91 | — | Matt Hewitt56% | — | Downgrade | Buy → Hold | Get Alert |
| 11/28/2016 | TDOC | Buy Now | Teladoc Health | $6.91 | — | Matt Hewitt56% | — | Initiates | → Buy | Get Alert |
| 02/22/2016 | RGEN | Buy Now | Repligen | $118.75 | — | Matt Hewitt56% | — | Initiates | → Buy | Get Alert |
| 05/12/2015 | LGND | Buy Now | Ligand Pharmaceuticals | $114.07 | -7.95% | Matt Hewitt56% | $90 → $105 | Maintains | Buy | Get Alert |
| 04/24/2015 | VCRA | Buy Now | Vocera Communications | — | — | Matt Hewitt56% | — | Upgrade | Hold → Buy | Get Alert |
| 08/01/2014 | VCRA | Buy Now | Vocera Communications | — | — | Matt Hewitt56% | $23 → $10 | Downgrade | Buy → Hold | Get Alert |
| 04/09/2014 | OMCL | Buy Now | Omnicell | $28.03 | 17.73% | Matt Hewitt56% | $28 → $33 | Upgrade | Hold → Buy | Get Alert |
